iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Recruiting now
Conditions studied: Type 2 Diabetes, Hypertension, Chronic Kidney Disease, Heart Failure
In brief
To provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes, Hypertension, Heart failure and/or Chronic kidney diseases
Key facts
- Study ID
- NCT03549754
- Run by
- AstraZeneca
- People needed
- 35000
- Starts
- 2018-02-17
- Expected to finish
- 2030-12-31
- Last updated by the study team
- 2026-07-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Being 18 years or older
- Having type 2 diabetes, Hypertension, Heart Failure and/or chronic kidney disease
- Providing written informed consent to participate in the registry
You may not qualify if…
- Having a life-threatening co-morbidity with life expectancy below 1 year
- Participating in an interventional trial requiring informed consent
Where it is running
- Research Site — Colatina, Espírito Santo (ES), Brazil (enrolling)
- Research Site — Salvador, Estado de Bahia, Brazil (enrolling)
- Research Site — Brasília, Federal District, Brazil (enrolling)
- Research Site — Poços de Caldas, Minas Gerais, Brazil (enrolling)
- Research Site — Campina Grande do Sul, Paraná, Brazil (enrolling)
- Research Site — Curitiba, Paraná, Brazil (enrolling)
- Research Site — Teresina, Piauí (PI), Brazil (enrolling)
- Research Site — Santa Cruz do Sul, Rio Grande Do Sul (RS), Brazil (enrolling)
- Research Site — Goiânia, State of Goias, Brazil (enrolling)
- Research Site — Joinville, State of Santa Catarina, Brazil (enrolling)
- Research Site — Bragança Paulista, São Paulo, Brazil (enrolling)
- Research Site — São Caetano do Sul, São Paulo, Brazil (enrolling)
- Research Site — São Paulo, Brazil (enrolling)
- Research Site — São Paulo, Brazil (enrolling)
- Research Site — Providencia, Santiago Metropolitan, Chile (enrolling)
- Research Site — San José, Costa Rica (enrolling)
- Research Site — Abidjan, Côte d’Ivoire (enrolling)
- Research Site — Alexandria, Egypt (enrolling)
- Research Site — Cairo, Egypt (enrolling)
- Research Site — Giza, Egypt (enrolling)
- Research Site — Tbilisi, Georgia (enrolling)
- Research Site — Kumasi, Ghana (enrolling)
- Research Site — Wan Chai, Hong Kong (enrolling)
- Research Site — Ahmedabad, India (enrolling)
- Research Site — Fortaleza, Ceará, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.